News Theraclion

Stocks

ALTHE

FR0010120402

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-06-11 am EDT			5-day change	1st Jan Change
0.7400 ^EUR	-2.37%		+5.87%	+22.92%

Jun. 08	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
Jun. 05	Theraclion deploys first Sonovein system in China

All News

Mentions Relevance

Jun. 08	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
Jun. 08	Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code	BU
Jun. 05	Theraclion deploys first Sonovein system in China
Jun. 05	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
Jun. 04	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI
Jun. 04	Theraclion Announces First Clinical Deployment of Sonovein® in Hainan, China	BU
Jun. 01	Theraclion Announces the Success of the First International HIFU Congress in Parma, Where Promising Preliminary Results From Its Sonovein® SpeedPulse Were Presented	BU
Jun. 01	Theraclion Presents Promising Preliminary Results From Sonovein SpeedPulse At First International HIFU Congress	CI
May. 11	Theraclion : Inside Information / Other news releases	PU
May. 11	Theraclion raises nearly 6 million euros via units with warrants
May. 11	Theraclion Announces the Strong Success of Its Oversubscribed Capital Increase	BU
Apr. 20	France's Theraclion Targets EUR6 Million via Capital Increase	MT
Apr. 20	Theraclion : Inside Information / Operations of the issuer (acquisitions, sales...)	PU
Apr. 20	Theraclion launches 12.48 million unit rights issue
Apr. 20	Theraclion Announces the Launch of a Capital Increase Through the Issuance of ABSA (Shares With Share Warrants Attached), With Preferential Subscription Rights for Existing Shareholders, for a Gross Amount of €6 Million, Secured by Subscription...	BU
Apr. 16	Theraclion Publishes Its 2025 Financial Results and Provides an Update on Its Outlook	BU
Apr. 16	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Jan. 29	Theraclion Delivers a Structuring Year in 2025 and Prepares to Scale up	BU
Dec. 10	Theraclion Seeks US FDA Nod for Varicose Vein Treatment Platform	MT
Dec. 09	Theraclion Announces Sonovein Fda Submission Following A Strong Year of Regulatory and Clinical Achievements	CI
Dec. 09	Theraclion Announces Sonovein FDA Submission Following a Strong Year of Regulatory and Clinical Achievements	BU
25-10-29	Theraclion Reports Major Recent Developments and Announces Its 2025 Half-Year Financial Results	BU
25-10-21	Theraclion Secures Key Chinese Certification, Advancing Toward Market Access in China	BU
25-10-21	Theraclion Secures Key Chinese Certification, Advancing Toward Market Access in China	CI
25-09-24	Theraclion SA Received MDR Certification for Sonovein	CI